Rapid Dose Therapeutics Corp. (RDTCF)

OTCMKTS · Delayed Price · Currency is USD
0.1393
-0.0407 (-22.61%)
At close: Apr 8, 2025
822.52%
Market Cap 15.76M
Revenue (ttm) 1.15M
Net Income (ttm) -4.12M
Shares Out n/a
EPS (ttm) -0.03
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 200
Average Volume 29,470
Open 0.1840
Previous Close 0.1800
Day's Range 0.1393 - 0.1840
52-Week Range 0.0029 - 0.3900
Beta -0.03
RSI 50.37
Earnings Date May 29, 2025

About Rapid Dose Therapeutics

Rapid Dose Therapeutics Corp., a life sciences company, provides drug delivery technologies designed to enhance patient outcomes in Canada. The company offers QuickStrip/PharmaStrip, an oral fast-dissolving drug delivery system to rapidly release active molecule into the blood stream, such as pharmaceuticals, emulsified oils, and over-the-counter medicines; QuickStrip energy to deliver energizing caffeine; QuickStrip B12 to deliver vitamin B12 in the system; and QuickStrip sleep that delivers melatonin in the system, as well as dental products.... [Read more]

Industry Biotechnology
Sector Healthcare
CEO Mark Upsdell
Country Canada
Stock Exchange OTCMKTS
Ticker Symbol RDTCF
Full Company Profile

Financial Performance

In 2023, Rapid Dose Therapeutics's revenue was 1.02 million, an increase of 42.06% compared to the previous year's 718,298. Losses were -4.31 million, 13.0% more than in 2022.

Financial numbers in CAD Financial Statements

News

Rapid Dose Announces Payment in Shares for Quarterly Interest on Secured Debt

Burlington, Ontario--(Newsfile Corp. - January 7, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announced today that as contemplated in the secured convertible notes (the ...

3 months ago - Newsfile Corp

Rapid Dose Announces Proposed Private Placement Financing

BURLINGTON, Ontario--(BUSINESS WIRE)--Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE) today announced that it plans to complete a private placement financing (the “Financing”) for u...

2 years ago - Business Wire

Rapid Dose Therapeutics Provides Update on Failure to File Cease Trade Order

BURLINGTON, Ontario--(BUSINESS WIRE)--Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, announces t...

2 years ago - Business Wire

Rapid Dose Therapeutics to Participate in the Venture Mentoring Services Program in Partnership with Maryland Tech Council and Canada's Trade Commissioner Service

BURLINGTON, Ontario--(BUSINESS WIRE)--Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, is one of f...

2 years ago - Business Wire

Rapid Dose Therapeutics Enters Supplier and Purchase Agreement with a Leading Gas and Convenience Store Retailer for Nutraceutical and Vitamin Products

BURLINGTON, Ontario--(BUSINESS WIRE)--Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company focused on health and wellness leveraging an innovative, prop...

2 years ago - Business Wire

Rapid Dose Therapeutics Confirms Delay in Filing Annual Financial Statements and Issuance of Failure-to-File Cease Trade Order

BURLINGTON, Ontario--(BUSINESS WIRE)--Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, confirms th...

2 years ago - Business Wire

Rapid Dose Therapeutics Provides Bi-Weekly MCTO Status Update

BURLINGTON, Ontario--(BUSINESS WIRE)--Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, is providin...

2 years ago - Business Wire

Rapid Dose Therapeutics Announces Closing of First Tranche of Private Placement

BURLINGTON, Ontario--(BUSINESS WIRE)--Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, today annou...

2 years ago - Business Wire

Rapid Dose Therapeutics Announces Issuance of Management Cease Trade Order

BURLINGTON, Ontario--(BUSINESS WIRE)--Rapid Dose Therapeutics Corp. (“RDT”), (CSE: DOSE), a Canadian biotechnology company leveraging an innovative, proprietary oral delivery platform, announces that,...

3 years ago - Business Wire

Rapid Dose Therapeutics Announces Delay in Filing Annual Financial Statements

BURLINGTON, Ontario--(BUSINESS WIRE)--Rapid Dose Therapeutics Announces Delay in Filing Annual Financial Statements

3 years ago - Business Wire

Rapid Dose Therapeutics Corp Announces Proposed Private Placement

BURLINGTON, Ontario--(BUSINESS WIRE)--Rapid Dose Therapeutics Corp Announces Proposed Private Placement

3 years ago - Business Wire

Rapid Dose Therapeutics Closes First Tranche of Private Placement

BURLINGTON, Ontario--(BUSINESS WIRE)--Rapid Dose Therapeutics Closes First Tranche of Private Placement

3 years ago - Business Wire

Rapid Dose Therapeutics Provides Shareholder Update Regarding Vaccine Collaboration Agreement with Oakland Health Limited in the United Kingdom

BURLINGTON, Ontario--(BUSINESS WIRE)--Rapid Dose Therapeutics Corp. (“RDT”), (CSE: DOSE), a Canadian biotechnology company leveraging an innovative, proprietary oral delivery platform, provides the fo...

3 years ago - Business Wire

Rapid Dose Therapeutics and Skycare Compounding Labs to Provide Patients with a Novel Oral Delivery Option for Pharmaceutical Products

BURLINGTON, Ontario--(BUSINESS WIRE)--Rapid Dose Therapeutics and Skycare Compounding Labs to Provide Patients with a Novel Oral Delivery Option for Pharmaceutical Products

3 years ago - Business Wire

RD Therapeutics and Rapid Dose Therapeutics Participate in the CEPI Global Pandemic Preparedness Summit and Support the #100DaysMission

BURLINGTON, Ontario--(BUSINESS WIRE)-- #100DaysMission--Value of needle-free vaccination to be discussed at the CEPI Global Pandemic Preparedness Summit, supporting the #100DaysMission

3 years ago - Business Wire

Rapid Dose Therapeutics Announces Management Change

BURLINGTON, Ontario--(BUSINESS WIRE)--Rapid Dose Therapeutics announces management change

3 years ago - Business Wire

Rapid Dose Therapeutics Appoints Dr. Michael Glogauer to Advisory Board

BURLINGTON, Ontario--(BUSINESS WIRE)--Rapid Dose Therapeutics Appoints Dr. Michael Glogauer to Advisory Board

3 years ago - Business Wire

Rapid Dose Therapeutics and McMaster University's COVID-19 Vaccine Study Receives NSERC Research and Development Grant

BURLINGTON, Ontario--(BUSINESS WIRE)---- $DOSE--Today, Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE) and McMaster University (“McMaster”) are pleased to announce that the ongoing ...

3 years ago - Business Wire